Johnson Financial Statements From 2010 to 2024
| JNJ Stock | EUR 147.50 0.14 0.1% |
Check Johnson Johnson financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Johnson Johnson's main balance sheet or income statement drivers, such as , as well as many indicators such as . Johnson financial statements analysis is a perfect complement when working with Johnson Johnson Valuation or Volatility modules.
Johnson |
Johnson Johnson Company Return On Asset Analysis
Johnson Johnson's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Johnson Johnson Return On Asset | 0.0871 |
Most of Johnson Johnson's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Johnson Johnson is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Johnson Johnson has a Return On Asset of 0.0871. This is 101.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on asset for all Germany stocks is 162.21% lower than that of the firm.
Johnson Johnson Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Johnson Johnson's current stock value. Our valuation model uses many indicators to compare Johnson Johnson value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Johnson Johnson competition to find correlations between indicators driving Johnson Johnson's intrinsic value. More Info.Johnson Johnson is rated fifth overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Johnson Johnson is roughly 2.73 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Johnson Johnson's earnings, one of the primary drivers of an investment's value.About Johnson Johnson Financial Statements
Johnson Johnson stakeholders use historical fundamental indicators, such as Johnson Johnson's revenue or net income, to determine how well the company is positioned to perform in the future. Although Johnson Johnson investors may analyze each financial statement separately, they are all interrelated. For example, changes in Johnson Johnson's assets and liabilities are reflected in the revenues and expenses on Johnson Johnson's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Johnson Johnson. Please read more on our technical analysis and fundamental analysis pages.
Johnson Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. Johnson Johnson was founded in 1886 and is based in New Brunswick, New Jersey. JOHNSON JOHNSON operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 136000 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:Check out the analysis of Johnson Johnson Correlation against competitors. For more detail on how to invest in Johnson Stock please use our How to Invest in Johnson Johnson guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.